Brian Drazba
Plus aucun poste en cours
Fortune : 7 500 $ au 31/03/2024
Profil
Brian G.
Drazba served as Chief Financial & Accounting Officer, VP at Heron Therapeutics, Inc. from 2013 to 2017.
Prior to that, he was Chief Accounting Officer & VP-Finance at ISTA Pharmaceuticals, Inc. from 2009 to 2012, and Chief Accounting Officer & Senior Vice President at InSight Health Corp.
from 1992 to 2009.
He also held the position of Chief Accounting Officer & Senior Vice President at InSight Health Services Holdings Corp.
Mr. Drazba is currently serving as Secretary & Chief Financial & Accounting Officer at MEI Pharma, Inc. since 2017.
He received his undergraduate degree from the University of San Diego.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MEI PHARMA, INC.
0,03% | 30/10/2023 | 1 875 ( 0,03% ) | 7 500 $ | 31/03/2024 |
Anciens postes connus de Brian Drazba
| Sociétés | Poste | Fin |
|---|---|---|
| MEI PHARMA, INC. | Director of Finance/CFO | 01/08/2023 |
| HERON THERAPEUTICS, INC. | Director of Finance/CFO | 31/03/2017 |
ISTA Pharmaceuticals, Inc.
 ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Comptroller/Controller/Auditor | 01/06/2012 |
InSight Health Corp.
 InSight Health Corp. Medical/Nursing ServicesHealth Services InSight Health Corp. provides diagnostic imaging and therapeutic healthcare services. It provides services to patients, physicians, managed care entities, hospitals and other contractual customers. The company was founded in 1996 and is headquartered in St. Louis Park, MN. | Comptroller/Controller/Auditor | 01/01/2009 |
InSight Health Services Holdings Corp.
 InSight Health Services Holdings Corp. Medical/Nursing ServicesHealth Services Insight Health Services Holdings Corp. provides fixed site and mobile diagnostic imaging services. It offers magnetic resonance imaging, computed and positron emission tomography, as well as other radiological services. The company was founded in 2001 and is headquartered in St. Louis Park, MN. | Comptroller/Controller/Auditor | - |
Formation de Brian Drazba
| University of San Diego | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| HERON THERAPEUTICS, INC. | Health Technology |
| MEI PHARMA, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
ISTA Pharmaceuticals, Inc.
ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Health Technology |
InSight Health Corp.
InSight Health Corp. Medical/Nursing ServicesHealth Services InSight Health Corp. provides diagnostic imaging and therapeutic healthcare services. It provides services to patients, physicians, managed care entities, hospitals and other contractual customers. The company was founded in 1996 and is headquartered in St. Louis Park, MN. | Health Services |
InSight Health Services Holdings Corp.
InSight Health Services Holdings Corp. Medical/Nursing ServicesHealth Services Insight Health Services Holdings Corp. provides fixed site and mobile diagnostic imaging services. It offers magnetic resonance imaging, computed and positron emission tomography, as well as other radiological services. The company was founded in 2001 and is headquartered in St. Louis Park, MN. | Health Services |
